SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 35 filers reported holding SAB BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $420,406 | +88.6% | 506,513 | 0.0% | 0.01% | +75.0% |
| Q1 2023 | $222,866 | -25.4% | 506,513 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $298,792 | +863.8% | 506,513 | +1063.0% | 0.01% | +400.0% |
| Q3 2022 | $31,000 | -50.8% | 43,551 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $63,000 | -61.6% | 43,551 | 0.0% | 0.00% | -66.7% |
| Q1 2022 | $164,000 | -51.8% | 43,551 | 0.0% | 0.00% | -40.0% |
| Q4 2021 | $340,000 | – | 43,551 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 78,115 | $294,000 | 0.05% |
| Shaolin Capital Management LLC | 275,000 | $1,034,000 | 0.03% |
| Spectrum Management Group, LLC | 5,030 | $19,000 | 0.00% |
| Veritable, L.P. | 43,551 | $164,000 | 0.00% |
| ALPS ADVISORS INC | 45,083 | $170,000 | 0.00% |
| ETF MANAGERS GROUP, LLC | 13,187 | $34,000 | 0.00% |
| Qube Research & Technologies Ltd | 24,179 | $91,000 | 0.00% |
| NORTHERN TRUST CORP | 44,476 | $167,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 301,110 | $1,132,000 | 0.00% |